Position in BIIB
as of Jun 30, 2026
· filed Aug 17, 2026
Position Value
$583,578
New position
Shares Held
2,701
first reported quarter
Ownership
0.002%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#552
of 1,036 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Proficio Capital Partners LLC holds $32,931,118 across 11 Drug Manufacturers - General names. BIIB ranks #7 (1.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
14,566 | $17,470,898 | |
| 2 | MRK |
Merck & Co., Inc.
|
36,360 | $4,672,260 | |
| 3 | JNJ |
Johnson & Johnson
|
10,547 | $2,678,621 | |
| 4 | AMGN |
Amgen Inc
|
6,520 | $2,361,022 | |
| 5 | ABBV |
AbbVie Inc.
|
8,651 | $2,176,937 | |
| 6 | AZN |
Astrazeneca PLC
|
7,518 | $1,425,563 | |
| 7 | BIIB |
Biogen Inc.
This page
|
2,701 | $583,578 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
4,405 | $556,527 |
All Filings in BIIB
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $583,578 | 2,701 | Shares | Sole | 2026-08-17 | |
| No filing history on record for this holder in this stock. | ||||||